Global Diabetes Management Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Diabetes Management Market Size Analysis

Global Diabetes Management Market Introduction
By Device Type
1. Introduction
  1. Device Type By Value
2. Monitoring Devices
  1. By Value
  2. Blood Glucose Meters
    1. Blood Glucose Meters By Value
  3. Lancets
    1. Lancets By Value
  4. Blood Sampling Devices
    1. Blood Sampling Devices By Value
  5. Other Devices
    1. Other Devices By Value
3. Diagnostic Devices
  1. By Value
  2. Hemoglobin A1 C
    1. Hemoglobin A1 C By Value
  3. Hemoglobin A1C kits
    1. Hemoglobin A1C kits By Value
  4. Hemoglobin A1C Meters
    1. Hemoglobin A1C Meters By Value
4. Insulin Delivery Devices
  1. By Value
  2. Insulin Pumps
    1. Insulin Pumps By Value
  3. Insulin Pens
    1. Insulin Pens By Value
  4. Insulin Syringes
    1. Insulin Syringes By Value
  5. Prefilled Insulin Syringes
    1. Prefilled Insulin Syringes By Value
5. Other Devices
  1. By Value
  2. Artificial Pancreas
    1. Artificial Pancreas By Value
  3. Commercial Software
    1. Commercial Software By Value
  4. Software Programs for Diabetes Monitoring
    1. Software Programs for Diabetes Monitoring By Value
By Therapeutics
1. Introduction
  1. Therapeutics By Value
2. Injectables
  1. By Value
  2. Insulin
    1. Insulin By Value
  3. Exenatide
    1. Exenatide By Value
3. Oral Drugs
  1. By Value
  2. Metformin
    1. Metformin By Value
  3. Sulfonylureas
    1. Sulfonylureas By Value
  4. Alpha glycosidase Inhibitors
    1. Alpha glycosidase Inhibitors By Value
  5. Dipeptidyl Inhibitors
    1. Dipeptidyl Inhibitors By Value
  6. Meglitinides
    1. Meglitinides By Value
  7. Thaizolidinediones
    1. Thaizolidinediones By Value
  8. Combination Medications
    1. Combination Medications By Value

North America Market Analysis

Introduction
By Device Type
1. Introduction
  1. Device Type By Value
2. Monitoring Devices
  1. By Value
  2. Blood Glucose Meters
    1. Blood Glucose Meters By Value
  3. Lancets
    1. Lancets By Value
  4. Blood Sampling Devices
    1. Blood Sampling Devices By Value
  5. Other Devices
    1. Other Devices By Value
3. Diagnostic Devices
  1. By Value
  2. Hemoglobin A1 C
    1. Hemoglobin A1 C By Value
  3. Hemoglobin A1C kits
    1. Hemoglobin A1C kits By Value
  4. Hemoglobin A1C Meters
    1. Hemoglobin A1C Meters By Value
4. Insulin Delivery Devices
  1. By Value
  2. Insulin Pumps
    1. Insulin Pumps By Value
  3. Insulin Pens
    1. Insulin Pens By Value
  4. Insulin Syringes
    1. Insulin Syringes By Value
  5. Prefilled Insulin Syringes
    1. Prefilled Insulin Syringes By Value
5. Other Devices
  1. By Value
  2. Artificial Pancreas
    1. Artificial Pancreas By Value
  3. Commercial Software
    1. Commercial Software By Value
  4. Software Programs for Diabetes Monitoring
    1. Software Programs for Diabetes Monitoring By Value
By Therapeutics
1. Introduction
  1. Therapeutics By Value
2. Injectables
  1. By Value
  2. Insulin
    1. Insulin By Value
  3. Exenatide
    1. Exenatide By Value
3. Oral Drugs
  1. By Value
  2. Metformin
    1. Metformin By Value
  3. Sulfonylureas
    1. Sulfonylureas By Value
  4. Alpha glycosidase Inhibitors
    1. Alpha glycosidase Inhibitors By Value
  5. Dipeptidyl Inhibitors
    1. Dipeptidyl Inhibitors By Value
  6. Meglitinides
    1. Meglitinides By Value
  7. Thaizolidinediones
    1. Thaizolidinediones By Value
  8. Combination Medications
    1. Combination Medications By Value
U.S.
1. By Device Type
  1. Introduction
    1. Device Type By Value
  2. Monitoring Devices
    1. By Value
    2. Blood Glucose Meters
      1. Blood Glucose Meters By Value
    3. Lancets
      1. Lancets By Value
    4. Blood Sampling Devices
      1. Blood Sampling Devices By Value
    5. Other Devices
      1. Other Devices By Value
  3. Diagnostic Devices
    1. By Value
    2. Hemoglobin A1 C
      1. Hemoglobin A1 C By Value
    3. Hemoglobin A1C kits
      1. Hemoglobin A1C kits By Value
    4. Hemoglobin A1C Meters
      1. Hemoglobin A1C Meters By Value
  4. Insulin Delivery Devices
    1. By Value
    2. Insulin Pumps
      1. Insulin Pumps By Value
    3. Insulin Pens
      1. Insulin Pens By Value
    4. Insulin Syringes
      1. Insulin Syringes By Value
    5. Prefilled Insulin Syringes
      1. Prefilled Insulin Syringes By Value
  5. Other Devices
    1. By Value
    2. Artificial Pancreas
      1. Artificial Pancreas By Value
    3. Commercial Software
      1. Commercial Software By Value
    4. Software Programs for Diabetes Monitoring
      1. Software Programs for Diabetes Monitoring By Value
2. By Therapeutics
  1. Introduction
    1. Therapeutics By Value
  2. Injectables
    1. By Value
    2. Insulin
      1. Insulin By Value
    3. Exenatide
      1. Exenatide By Value
  3. Oral Drugs
    1. By Value
    2. Metformin
      1. Metformin By Value
    3. Sulfonylureas
      1. Sulfonylureas By Value
    4. Alpha glycosidase Inhibitors
      1. Alpha glycosidase Inhibitors By Value
    5. Dipeptidyl Inhibitors
      1. Dipeptidyl Inhibitors By Value
    6. Meglitinides
      1. Meglitinides By Value
    7. Thaizolidinediones
      1. Thaizolidinediones By Value
    8. Combination Medications
      1. Combination Medications By Value
Canada

Europe Market Analysis

Introduction
By Device Type
1. Introduction
  1. Device Type By Value
2. Monitoring Devices
  1. By Value
  2. Blood Glucose Meters
    1. Blood Glucose Meters By Value
  3. Lancets
    1. Lancets By Value
  4. Blood Sampling Devices
    1. Blood Sampling Devices By Value
  5. Other Devices
    1. Other Devices By Value
3. Diagnostic Devices
  1. By Value
  2. Hemoglobin A1 C
    1. Hemoglobin A1 C By Value
  3. Hemoglobin A1C kits
    1. Hemoglobin A1C kits By Value
  4. Hemoglobin A1C Meters
    1. Hemoglobin A1C Meters By Value
4. Insulin Delivery Devices
  1. By Value
  2. Insulin Pumps
    1. Insulin Pumps By Value
  3. Insulin Pens
    1. Insulin Pens By Value
  4. Insulin Syringes
    1. Insulin Syringes By Value
  5. Prefilled Insulin Syringes
    1. Prefilled Insulin Syringes By Value
5. Other Devices
  1. By Value
  2. Artificial Pancreas
    1. Artificial Pancreas By Value
  3. Commercial Software
    1. Commercial Software By Value
  4. Software Programs for Diabetes Monitoring
    1. Software Programs for Diabetes Monitoring By Value
By Therapeutics
1. Introduction
  1. Therapeutics By Value
2. Injectables
  1. By Value
  2. Insulin
    1. Insulin By Value
  3. Exenatide
    1. Exenatide By Value
3. Oral Drugs
  1. By Value
  2. Metformin
    1. Metformin By Value
  3. Sulfonylureas
    1. Sulfonylureas By Value
  4. Alpha glycosidase Inhibitors
    1. Alpha glycosidase Inhibitors By Value
  5. Dipeptidyl Inhibitors
    1. Dipeptidyl Inhibitors By Value
  6. Meglitinides
    1. Meglitinides By Value
  7. Thaizolidinediones
    1. Thaizolidinediones By Value
  8. Combination Medications
    1. Combination Medications By Value
U.K.
1. By Device Type
  1. Introduction
    1. Device Type By Value
  2. Monitoring Devices
    1. By Value
    2. Blood Glucose Meters
      1. Blood Glucose Meters By Value
    3. Lancets
      1. Lancets By Value
    4. Blood Sampling Devices
      1. Blood Sampling Devices By Value
    5. Other Devices
      1. Other Devices By Value
  3. Diagnostic Devices
    1. By Value
    2. Hemoglobin A1 C
      1. Hemoglobin A1 C By Value
    3. Hemoglobin A1C kits
      1. Hemoglobin A1C kits By Value
    4. Hemoglobin A1C Meters
      1. Hemoglobin A1C Meters By Value
  4. Insulin Delivery Devices
    1. By Value
    2. Insulin Pumps
      1. Insulin Pumps By Value
    3. Insulin Pens
      1. Insulin Pens By Value
    4. Insulin Syringes
      1. Insulin Syringes By Value
    5. Prefilled Insulin Syringes
      1. Prefilled Insulin Syringes By Value
  5. Other Devices
    1. By Value
    2. Artificial Pancreas
      1. Artificial Pancreas By Value
    3. Commercial Software
      1. Commercial Software By Value
    4. Software Programs for Diabetes Monitoring
      1. Software Programs for Diabetes Monitoring By Value
2. By Therapeutics
  1. Introduction
    1. Therapeutics By Value
  2. Injectables
    1. By Value
    2. Insulin
      1. Insulin By Value
    3. Exenatide
      1. Exenatide By Value
  3. Oral Drugs
    1. By Value
    2. Metformin
      1. Metformin By Value
    3. Sulfonylureas
      1. Sulfonylureas By Value
    4. Alpha glycosidase Inhibitors
      1. Alpha glycosidase Inhibitors By Value
    5. Dipeptidyl Inhibitors
      1. Dipeptidyl Inhibitors By Value
    6. Meglitinides
      1. Meglitinides By Value
    7. Thaizolidinediones
      1. Thaizolidinediones By Value
    8. Combination Medications
      1. Combination Medications By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Device Type
1. Introduction
  1. Device Type By Value
2. Monitoring Devices
  1. By Value
  2. Blood Glucose Meters
    1. Blood Glucose Meters By Value
  3. Lancets
    1. Lancets By Value
  4. Blood Sampling Devices
    1. Blood Sampling Devices By Value
  5. Other Devices
    1. Other Devices By Value
3. Diagnostic Devices
  1. By Value
  2. Hemoglobin A1 C
    1. Hemoglobin A1 C By Value
  3. Hemoglobin A1C kits
    1. Hemoglobin A1C kits By Value
  4. Hemoglobin A1C Meters
    1. Hemoglobin A1C Meters By Value
4. Insulin Delivery Devices
  1. By Value
  2. Insulin Pumps
    1. Insulin Pumps By Value
  3. Insulin Pens
    1. Insulin Pens By Value
  4. Insulin Syringes
    1. Insulin Syringes By Value
  5. Prefilled Insulin Syringes
    1. Prefilled Insulin Syringes By Value
5. Other Devices
  1. By Value
  2. Artificial Pancreas
    1. Artificial Pancreas By Value
  3. Commercial Software
    1. Commercial Software By Value
  4. Software Programs for Diabetes Monitoring
    1. Software Programs for Diabetes Monitoring By Value
By Therapeutics
1. Introduction
  1. Therapeutics By Value
2. Injectables
  1. By Value
  2. Insulin
    1. Insulin By Value
  3. Exenatide
    1. Exenatide By Value
3. Oral Drugs
  1. By Value
  2. Metformin
    1. Metformin By Value
  3. Sulfonylureas
    1. Sulfonylureas By Value
  4. Alpha glycosidase Inhibitors
    1. Alpha glycosidase Inhibitors By Value
  5. Dipeptidyl Inhibitors
    1. Dipeptidyl Inhibitors By Value
  6. Meglitinides
    1. Meglitinides By Value
  7. Thaizolidinediones
    1. Thaizolidinediones By Value
  8. Combination Medications
    1. Combination Medications By Value
China
1. By Device Type
  1. Introduction
    1. Device Type By Value
  2. Monitoring Devices
    1. By Value
    2. Blood Glucose Meters
      1. Blood Glucose Meters By Value
    3. Lancets
      1. Lancets By Value
    4. Blood Sampling Devices
      1. Blood Sampling Devices By Value
    5. Other Devices
      1. Other Devices By Value
  3. Diagnostic Devices
    1. By Value
    2. Hemoglobin A1 C
      1. Hemoglobin A1 C By Value
    3. Hemoglobin A1C kits
      1. Hemoglobin A1C kits By Value
    4. Hemoglobin A1C Meters
      1. Hemoglobin A1C Meters By Value
  4. Insulin Delivery Devices
    1. By Value
    2. Insulin Pumps
      1. Insulin Pumps By Value
    3. Insulin Pens
      1. Insulin Pens By Value
    4. Insulin Syringes
      1. Insulin Syringes By Value
    5. Prefilled Insulin Syringes
      1. Prefilled Insulin Syringes By Value
  5. Other Devices
    1. By Value
    2. Artificial Pancreas
      1. Artificial Pancreas By Value
    3. Commercial Software
      1. Commercial Software By Value
    4. Software Programs for Diabetes Monitoring
      1. Software Programs for Diabetes Monitoring By Value
2. By Therapeutics
  1. Introduction
    1. Therapeutics By Value
  2. Injectables
    1. By Value
    2. Insulin
      1. Insulin By Value
    3. Exenatide
      1. Exenatide By Value
  3. Oral Drugs
    1. By Value
    2. Metformin
      1. Metformin By Value
    3. Sulfonylureas
      1. Sulfonylureas By Value
    4. Alpha glycosidase Inhibitors
      1. Alpha glycosidase Inhibitors By Value
    5. Dipeptidyl Inhibitors
      1. Dipeptidyl Inhibitors By Value
    6. Meglitinides
      1. Meglitinides By Value
    7. Thaizolidinediones
      1. Thaizolidinediones By Value
    8. Combination Medications
      1. Combination Medications By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Device Type
1. Introduction
  1. Device Type By Value
2. Monitoring Devices
  1. By Value
  2. Blood Glucose Meters
    1. Blood Glucose Meters By Value
  3. Lancets
    1. Lancets By Value
  4. Blood Sampling Devices
    1. Blood Sampling Devices By Value
  5. Other Devices
    1. Other Devices By Value
3. Diagnostic Devices
  1. By Value
  2. Hemoglobin A1 C
    1. Hemoglobin A1 C By Value
  3. Hemoglobin A1C kits
    1. Hemoglobin A1C kits By Value
  4. Hemoglobin A1C Meters
    1. Hemoglobin A1C Meters By Value
4. Insulin Delivery Devices
  1. By Value
  2. Insulin Pumps
    1. Insulin Pumps By Value
  3. Insulin Pens
    1. Insulin Pens By Value
  4. Insulin Syringes
    1. Insulin Syringes By Value
  5. Prefilled Insulin Syringes
    1. Prefilled Insulin Syringes By Value
5. Other Devices
  1. By Value
  2. Artificial Pancreas
    1. Artificial Pancreas By Value
  3. Commercial Software
    1. Commercial Software By Value
  4. Software Programs for Diabetes Monitoring
    1. Software Programs for Diabetes Monitoring By Value
By Therapeutics
1. Introduction
  1. Therapeutics By Value
2. Injectables
  1. By Value
  2. Insulin
    1. Insulin By Value
  3. Exenatide
    1. Exenatide By Value
3. Oral Drugs
  1. By Value
  2. Metformin
    1. Metformin By Value
  3. Sulfonylureas
    1. Sulfonylureas By Value
  4. Alpha glycosidase Inhibitors
    1. Alpha glycosidase Inhibitors By Value
  5. Dipeptidyl Inhibitors
    1. Dipeptidyl Inhibitors By Value
  6. Meglitinides
    1. Meglitinides By Value
  7. Thaizolidinediones
    1. Thaizolidinediones By Value
  8. Combination Medications
    1. Combination Medications By Value
UAE
1. By Device Type
  1. Introduction
    1. Device Type By Value
  2. Monitoring Devices
    1. By Value
    2. Blood Glucose Meters
      1. Blood Glucose Meters By Value
    3. Lancets
      1. Lancets By Value
    4. Blood Sampling Devices
      1. Blood Sampling Devices By Value
    5. Other Devices
      1. Other Devices By Value
  3. Diagnostic Devices
    1. By Value
    2. Hemoglobin A1 C
      1. Hemoglobin A1 C By Value
    3. Hemoglobin A1C kits
      1. Hemoglobin A1C kits By Value
    4. Hemoglobin A1C Meters
      1. Hemoglobin A1C Meters By Value
  4. Insulin Delivery Devices
    1. By Value
    2. Insulin Pumps
      1. Insulin Pumps By Value
    3. Insulin Pens
      1. Insulin Pens By Value
    4. Insulin Syringes
      1. Insulin Syringes By Value
    5. Prefilled Insulin Syringes
      1. Prefilled Insulin Syringes By Value
  5. Other Devices
    1. By Value
    2. Artificial Pancreas
      1. Artificial Pancreas By Value
    3. Commercial Software
      1. Commercial Software By Value
    4. Software Programs for Diabetes Monitoring
      1. Software Programs for Diabetes Monitoring By Value
2. By Therapeutics
  1. Introduction
    1. Therapeutics By Value
  2. Injectables
    1. By Value
    2. Insulin
      1. Insulin By Value
    3. Exenatide
      1. Exenatide By Value
  3. Oral Drugs
    1. By Value
    2. Metformin
      1. Metformin By Value
    3. Sulfonylureas
      1. Sulfonylureas By Value
    4. Alpha glycosidase Inhibitors
      1. Alpha glycosidase Inhibitors By Value
    5. Dipeptidyl Inhibitors
      1. Dipeptidyl Inhibitors By Value
    6. Meglitinides
      1. Meglitinides By Value
    7. Thaizolidinediones
      1. Thaizolidinediones By Value
    8. Combination Medications
      1. Combination Medications By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Device Type
1. Introduction
  1. Device Type By Value
2. Monitoring Devices
  1. By Value
  2. Blood Glucose Meters
    1. Blood Glucose Meters By Value
  3. Lancets
    1. Lancets By Value
  4. Blood Sampling Devices
    1. Blood Sampling Devices By Value
  5. Other Devices
    1. Other Devices By Value
3. Diagnostic Devices
  1. By Value
  2. Hemoglobin A1 C
    1. Hemoglobin A1 C By Value
  3. Hemoglobin A1C kits
    1. Hemoglobin A1C kits By Value
  4. Hemoglobin A1C Meters
    1. Hemoglobin A1C Meters By Value
4. Insulin Delivery Devices
  1. By Value
  2. Insulin Pumps
    1. Insulin Pumps By Value
  3. Insulin Pens
    1. Insulin Pens By Value
  4. Insulin Syringes
    1. Insulin Syringes By Value
  5. Prefilled Insulin Syringes
    1. Prefilled Insulin Syringes By Value
5. Other Devices
  1. By Value
  2. Artificial Pancreas
    1. Artificial Pancreas By Value
  3. Commercial Software
    1. Commercial Software By Value
  4. Software Programs for Diabetes Monitoring
    1. Software Programs for Diabetes Monitoring By Value
By Therapeutics
1. Introduction
  1. Therapeutics By Value
2. Injectables
  1. By Value
  2. Insulin
    1. Insulin By Value
  3. Exenatide
    1. Exenatide By Value
3. Oral Drugs
  1. By Value
  2. Metformin
    1. Metformin By Value
  3. Sulfonylureas
    1. Sulfonylureas By Value
  4. Alpha glycosidase Inhibitors
    1. Alpha glycosidase Inhibitors By Value
  5. Dipeptidyl Inhibitors
    1. Dipeptidyl Inhibitors By Value
  6. Meglitinides
    1. Meglitinides By Value
  7. Thaizolidinediones
    1. Thaizolidinediones By Value
  8. Combination Medications
    1. Combination Medications By Value
Brazil
1. By Device Type
  1. Introduction
    1. Device Type By Value
  2. Monitoring Devices
    1. By Value
    2. Blood Glucose Meters
      1. Blood Glucose Meters By Value
    3. Lancets
      1. Lancets By Value
    4. Blood Sampling Devices
      1. Blood Sampling Devices By Value
    5. Other Devices
      1. Other Devices By Value
  3. Diagnostic Devices
    1. By Value
    2. Hemoglobin A1 C
      1. Hemoglobin A1 C By Value
    3. Hemoglobin A1C kits
      1. Hemoglobin A1C kits By Value
    4. Hemoglobin A1C Meters
      1. Hemoglobin A1C Meters By Value
  4. Insulin Delivery Devices
    1. By Value
    2. Insulin Pumps
      1. Insulin Pumps By Value
    3. Insulin Pens
      1. Insulin Pens By Value
    4. Insulin Syringes
      1. Insulin Syringes By Value
    5. Prefilled Insulin Syringes
      1. Prefilled Insulin Syringes By Value
  5. Other Devices
    1. By Value
    2. Artificial Pancreas
      1. Artificial Pancreas By Value
    3. Commercial Software
      1. Commercial Software By Value
    4. Software Programs for Diabetes Monitoring
      1. Software Programs for Diabetes Monitoring By Value
2. By Therapeutics
  1. Introduction
    1. Therapeutics By Value
  2. Injectables
    1. By Value
    2. Insulin
      1. Insulin By Value
    3. Exenatide
      1. Exenatide By Value
  3. Oral Drugs
    1. By Value
    2. Metformin
      1. Metformin By Value
    3. Sulfonylureas
      1. Sulfonylureas By Value
    4. Alpha glycosidase Inhibitors
      1. Alpha glycosidase Inhibitors By Value
    5. Dipeptidyl Inhibitors
      1. Dipeptidyl Inhibitors By Value
    6. Meglitinides
      1. Meglitinides By Value
    7. Thaizolidinediones
      1. Thaizolidinediones By Value
    8. Combination Medications
      1. Combination Medications By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Diabetes Management Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Bayer AG
Bristol-Myers Squibb
Lilly
Sanofi
Dexcom
Medtronic
Trinity Biotech
Novo Nordisk A/S
Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Boehringer Ingelheim
Takeda Pharmaceutical
Pfizer
Ascensia Diabetes Care
Insulet Corporation
Braun Melsungen

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment